• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

153.62 +7.21 (+4.92%)
Streaming Delayed Price Updated: 1:53 PM EDT, Jun 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions
June 04, 2026
From Insulet Corporation
Via Business Wire
News headline image
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor
June 03, 2026
From Insulet Corporation
Via Business Wire
News headline image
Insulet to Participate in William Blair 46th Annual Growth Stock Conference
May 27, 2026
From Insulet Corporation
Via Business Wire
News headline image
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets
May 26, 2026
From Insulet Corporation
Via Business Wire
News headline image
Insulet Reports First Quarter 2026 Results
May 06, 2026
From Insulet Corporation
Via Business Wire
News headline image
Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities
May 05, 2026
From Insulet Corporation
Via Business Wire
News headline image
Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes
May 04, 2026
From Insulet Corporation
Via Business Wire
News headline image
Insulet to Participate in BofA Securities 2026 Health Care Conference
April 28, 2026
From Insulet Corporation
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
April 21, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
April 14, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
April 07, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026
April 01, 2026
From Insulet Corporation
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
March 31, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Insulet Appoints Mike Panos as Chief Commercial Officer
March 30, 2026
From Insulet Corporation
Via Business Wire
News headline image
PODD Investors Have Opportunity to Join Insulet Corporation Fraud Investigation with the Schall Law Firm
March 28, 2026
From The Schall Law Firm
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
March 24, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Securities Fraud Investigation Into Insulet Corporation (PODD) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
March 19, 2026
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Securities Fraud Investigation Into Insulet Corporation (PODD) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
March 18, 2026
From Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Insulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
March 18, 2026
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
March 17, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
March 13, 2026
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Insulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
March 13, 2026
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
March 13, 2026
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.
March 12, 2026
From Insulet Corporation, Inc.
Via Business Wire
News headline image
Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes
March 11, 2026
From Insulet Corporation
Via Business Wire
News headline image
Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
March 10, 2026
From Insulet Corporation
Via Business Wire
News headline image
Insulet Reports Fourth Quarter and Full Year 2025 Results
February 18, 2026
From Insulet Corporation
Via Business Wire
News headline image
Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care
February 05, 2026
From Insulet Corporation
Via Business Wire
News headline image
Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026
January 09, 2026
From Insulet Corporation
Via Business Wire
News headline image
Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health
January 06, 2026
From Insulet Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap